🇨🇦 Buprenorphine patch and sublingual tablets in Canada

Buprenorphine patch and sublingual tablets (Buprenorphine patch and sublingual tablets) regulatory status in Canada.

Marketing authorisation

Buprenorphine patch and sublingual tablets in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Buprenorphine patch and sublingual tablets approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Buprenorphine patch and sublingual tablets in Canada?

Psychiatric University Hospital, Zurich is the originator. The local marketing authorisation holder may differ — check the official source linked above.